Analysis of Influencing Factors and Construction of Prediction Models of Artificial Joint Replacement in China

Knee Arthropathy Clinical Trial

Official title:

Analysis of Influencing Factors and Construction of Prediction Models of Artificial Joint Replacement in China

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05170321
• Other study ID #: 2017121016
• Status: Active, not recruiting
• Start date: January 1, 2018
• Est. completion date: December 1, 2022

Study information

• Verified date: November 2021
• Source: Xiangya Hospital of Central South University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The project intends to analyze the epidemiological characteristics, risk factors, complications and resource utilization of artificial joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The HQMS database is a mandatory electronic inpatient database system developed by the National Health Commission of the People's Republic of China. Since 2013, tertiary hospitals have been required to upload their inpatient discharge records. By 2019, the HQMS database has included more than 230 million standardized inpatient discharge records of over 1000 hospitals across all 31 provincial-level administrative regions in mainland China. Patient demographics, clinical diagnosis, procedures and operations, drug use, costs and complications were all recorded in the HQMS database. The investigators planned to include five types of arthroplasty, including knee arthroplasty, hip arthroplasty, shoulder arthroplasty, ankle arthroplasty and elbow arthroplasty. The data analysis will be conformed to the principle of confidentiality and will not reveal the privacy of those patients. The data will be only used for this research project and there is no conflict of interest. It is in line with the principles of ethics, harmlessness and fairness. This study was authorized by the HQMS Committee Board and approved by the institutional review board, with waiver of informed consent.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 600000
• Est. completion date: December 1, 2022
• Est. primary completion date: December 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients who underwent knee, hip, shoulder, ankle and elbow arthroplasty in HQMS

Exclusion Criteria:

• Patients who didn't undergo knee, hip, shoulder, ankle and elbow arthroplasty
• Patients with missing demographics or medical data

Related Conditions & MeSH terms

• Ankle Arthropathy
• Elbow Arthropathy
• Hip Arthropathy
• Joint Diseases
• Knee Arthropathy
• Shoulder Arthropathy

Locations

Country	Name	City	State
China	Xiangya Hospital of Central South University	Changsha	Hunan

Sponsors (1)

Lead Sponsor	Collaborator
Xiangya Hospital of Central South University

Country where clinical trial is conducted

China, 

References & Publications (1)

Zeng C, Lane NE, Englund M, Xie D, Chen H, Zhang Y, Wang H, Lei G. In-hospital mortality after hip arthroplasty in China: analysis of a large national database. Bone Joint J. 2019 Oct;101-B(10):1209-1217. doi: 10.1302/0301-620X.101B10.BJJ-2018-1608.R1. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Epidemiological characteristics, complications, risk factors and resource utilization of knee arthroplasty in China	The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial knee joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.	10 years (2013-2022)
Primary	Epidemiological characteristics, complications, risk factors and resource utilization of hip arthroplasty in China	The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial hip joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.	10 years (2013-2022)
Primary	Epidemiological characteristics, complications, risk factors and resource utilization of shoulder arthroplasty in China	The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial shoulder joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.	10 years (2013-2022)
Primary	Epidemiological characteristics, complications, risk factors and resource utilization of ankle arthroplasty in China	The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial ankle joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.	10 years (2013-2022)
Primary	Epidemiological characteristics, complications, risk factors and resource utilization of elbow arthroplasty in China	The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial elbow joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.	10 years (2013-2022)